Relief received CHF 1.2 million upfront from Nutrisens and is eligible for certain contingent payments. Following this payment, Relief reported a cash balance of CHF 15.3 million as of January 22, ...

Upgrades are coming to Alix Goolden Performance Hall as part of a city grant, and could include a plaza co-created with Our ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

With these agreements, the respective parties will work to advance therapeutic candidates for treating fibrotic diseases, osteoarthritis, and Alzheimer’s disease.

In a bid to help the immune system of autoimmune disease patients reset, a San Francisco startup startup has raised $120 ...

Nimbus plans to initiate the first clinical trial of NDI-219216 in the first half of 2025 under the leadership of Anita Scheuber, M.D., Ph.D., Senior Vice President, Therapeutic Area Head ...

Nimbus plans to initiate the first clinical trial of NDI-219216 in the first half of 2025 under the leadership of Anita Scheuber, M.D., Ph.D., Senior Vice President, Therapeutic Area Head, Oncology.

One of the challenges that awaited me, however, as I took on the position of medical director of the MedPsych unit at Hasbro Children’s Hospital, was the emphasis on consistent, therapeutic ...

As the CEO of an e-commerce marketing automation platform, here are three areas of e-commerce I’m watching in 2025. President-elect Donald Trump has proposed instituting tariffs on all imported ...